109-51-3

Basic information

• Product Name: PENTANAMIDINE
• Synonyms: pentanimidamide(SALTDATA: HCl);PentanoaMidine;ValeraMidine
• CAS NO: 109-51-3
• Molecular Formula: C₅H₁₂N₂
• Molecular Weight: 100.16
• Mol File: 109-51-3.mol

Chemical Properties

• Boiling Point: 141.9°C at 760 mmHg
• Flash Point: 39.6°C
• Appearance: /
• Density: 0.95g/cm³
• Vapor Pressure: 5.72mmHg at 25°C
• Refractive Index: 1.467
• CAS DataBase Reference: PENTANAMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: PENTANAMIDINE(109-51-3)
• EPA Substance Registry System: PENTANAMIDINE(109-51-3)

Safety Data

• Hazardous Substances Data: 109-51-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
PENTANAMIDINE is used as an antiprotozoal and antimicrobial agent for the treatment of Pneumocystis jiroveci pneumonia in patients with AIDS. It is effective against a range of protozoal infections, including leishmaniasis, trypanosomiasis, and malaria, by interfering with the growth and reproduction of the causative protozoa.
Used in Infectious Disease Management:
PENTANAMIDINE is used as a preventive and therapeutic agent for various protozoal infections, helping to control and eradicate these diseases in patients who have failed other treatments or cannot tolerate other medications.
Used in Patient Care:
PENTANAMIDINE is used as a medication for patients with compromised immune systems or those who are intolerant to other treatments, providing an alternative option for managing severe protozoal infections.

InChI:InChI=1/C5H12N2/c1-2-3-4-5(6)7/h2-4H2,1H3,(H3,6,7)

Upstream product

• 110-59-8 pentanonitrile 
• 39800-84-5 propamidine 
• 107-12-0 propiononitrile 

Downstream Products

• 1313233-75-8 methyl 2-butyl-1-[(2'-cyanobiphenyl-4-yl)methyl]-4-(4-fluorophenyl)-1H-imidazole-5-carboxylic acid 
• 1313233-73-6 4'-{[2-butyl-4-(4-fluorophenyl)-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl}-N'-hydroxybiphenyl-2-carboximidamide 
• 1313233-74-7 2-butyl-1-{(2'-cyanobiphenyl-4-yl)methyl}-4-(4-fluorophenyl)-1H-imidazole-5-carboxylic acid 
• 1313233-72-5 4'-[{2-butyl-4-(4-fluorophenyl)-5-(hydroxymethyl)-1H-imidazol-1-yl}methyl]biphenyl-2-carbonitrile 
• 1313233-71-4 4'-[{2-butyl-4-(4-fluorophenyl)-5-formyl-1H-imidazol-1-yl}methyl]biphenyl-2-carbonitrile 
• 1313233-70-3 2-butyl-4-(4-fluorophenyl)-1H-imidazole-5-carbaldehyde 
• 1313233-69-0 {2-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl}methanol 
• 1313233-49-6 3-[4'-[{2-butyl-4-(4-fluorophenyl)-5-(hydroxymethyl)-1H-imidazol-1-yl}methyl]biphenyl-2-yl]-1,2,4-oxadiazol-5(4H)-one 
• 1313233-68-9 2-butyl-4-(4-fluorophenyl)-1H-imidazole 
• 158365-99-2 2-butyl-5-chloro-1H-imidazole 
• 83857-96-9 2-n-butyl-4-chloro-1H-imidazol-5-carboxaldehyde 
• 106-97-8 n-butane 

Relevant articles and documents

Dual antagonist of angiotensin II receptor and endothelin receptor

The invention relates to dual antagonists of an angiotensin II receptor and an endothelin receptor. Specifically, the invention provides a compound represented by a formula I and a preparation method thereof. The compound can be used for treating diseases

Pyrimidinone derivatives

The invention relates to pyrimidinone derivatives and the pharmaceutically acceptable salts thereof having remarkable antagonistic action against angiotensin II receptor, and thus useful in treating cardiovascular diseases caused by angiotensin II.